Expression and purification of lipoprotein-associated phospholipase A(2), a key enzyme involved in atherosclerosis.

about

OxLDL stimulates lipoprotein-associated phospholipase A2 expression in THP-1 monocytes via PI3K and p38 MAPK pathways.

P2860

Q39775481-CBADF5A9-D865-40DE-A34F-C6352361AB12

P2860

Expression and purification of lipoprotein-associated phospholipase A(2), a key enzyme involved in atherosclerosis.

Item

http://www.wikidata.org/entity/Q40275828

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Expression and purification of ...... e involved in atherosclerosis.

@en

type

Item

label

Expression and purification of ...... e involved in atherosclerosis.

@en

prefLabel

Expression and purification of ...... e involved in atherosclerosis.

@en

P1476

Expression and purification of ...... e involved in atherosclerosis.

@en

P2093

Fu-Jun Zhang

http://www.w3.org/2001/XMLSchema#string

Jing-Kang Shen

http://www.w3.org/2001/XMLSchema#string

Mao-Jun Cai

http://www.w3.org/2001/XMLSchema#string

Yi-Ping Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.

Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target.

Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target.

Lp-PLA2: an emerging biomarker of coronary heart disease.

Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase.

Lipoprotein-associated phospholipase A2 as a target of therapy.

Lipoprotein-associated phospholipase A2: a novel marker of cardiovascular risk and potential therapeutic target.

Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern G

P2888

j.1745-7254.2006.00308.x

P304

679-684

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1745-7254.2006.00308.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7059920

http://www.w3.org/2001/XMLSchema#string

P6179

1052756789

http://www.w3.org/2001/XMLSchema#string

P698

16723085

http://www.w3.org/2001/XMLSchema#string

Expression and purification of lipoprotein-associated phospholipase A(2), a key enzyme involved in atherosclerosis.

about

P2860

P2860

Expression and purification of lipoprotein-associated phospholipase A(2), a key enzyme involved in atherosclerosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698